As Germany looks to pick up the pace of testing for COVID-19, the interior ministry's target of carrying out 200,000 tests per day should be possible 'in the future', says Christian Dreher, head of test manufacturer R-Biopharm. But Dreher also highlights the importance of antibody tests to identify those who have survived the COVID-19 disease. IMAGES from a demonstration test AND SOUNDBITES from the CEO of R-BiopharmN°1QB8AG
